OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NSUN2 is a glucose sensor suppressing cGAS/STING to maintain tumorigenesis and immunotherapy resistance
Tingjin Chen, Zhigang Xu, Luo Jie, et al.
Cell Metabolism (2023) Vol. 35, Iss. 10, pp. 1782-1798.e8
Closed Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets
Shaosen Zhang, Xinyi Xiao, Yonglin Yi, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 31

Harnessing innate immune pathways for therapeutic advancement in cancer
An-Kang Hu, Li Sun, Hao Lin, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 27

The role of RNA methylation in tumor immunity and its potential in immunotherapy
Yan Li, Haoer Jin, Qingling Li, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 17

Emerging epigenetic insights into aging mechanisms and interventions
Zeming Wu, Weiqi Zhang, Jing Qu, et al.
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 2, pp. 157-172
Closed Access | Times Cited: 15

Cancer plasticity in therapy resistance: Mechanisms and novel strategies
Xing Niu, Wenjing Liu, Zhang Yinling, et al.
Drug Resistance Updates (2024) Vol. 76, pp. 101114-101114
Closed Access | Times Cited: 12

H3K18 Lactylation Potentiates Immune Escape of Non-Small Cell Lung Cancer
Zhang Cai, Lijie Zhou, Mingyuan Zhang, et al.
Cancer Research (2024) Vol. 84, Iss. 21, pp. 3589-3601
Closed Access | Times Cited: 12

Regulation of cGAS–STING signalling and its diversity of cellular outcomes
Zhengyin Zhang, Conggang Zhang
Nature reviews. Immunology (2025)
Closed Access | Times Cited: 1

IUPHAR ECR review: The cGAS-STING pathway: Novel functions beyond innate immune and emerging therapeutic opportunities
Xu He, Abdalla M. Wedn, Jian Wang, et al.
Pharmacological Research (2024) Vol. 201, pp. 107063-107063
Open Access | Times Cited: 11

Cancer immunometabolism: advent, challenges, and perspective
Qin Dang, Borui Li, Bing Jin, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 9

Emerging mechanisms and implications of cGAS-STING signaling in cancer immunotherapy strategies
Jiawen Zhang, Sihui Yu, Qiao Peng, et al.
Cancer Biology and Medicine (2024), pp. 1-20
Open Access | Times Cited: 6

Novel Modifications and Delivery Modes of Cyclic Dinucleotides for STING Activation in Cancer Treatment
Yanjun Lu, Zhiyan Li, Xudong Zhu, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 181-197
Open Access

DDX50 cooperates with STAU1 to effect stabilization of pro-differentiation RNAs
Weili Miao, Douglas F. Porter, Zurab Siprashvili, et al.
Cell Reports (2025) Vol. 44, Iss. 1, pp. 115174-115174
Open Access

RNA modifications in cancer
Han Wu, Shi Chen, Xiang Li, et al.
MedComm (2025) Vol. 6, Iss. 1
Open Access

Multi-omic and machine learning analysis of mitochondrial RNA modification genes in lung adenocarcinoma for prognostic and therapeutic implications
Xiao Zhang, Jiatao Liu, Yan‐Pei Cao, et al.
Translational Oncology (2025) Vol. 53, pp. 102306-102306
Closed Access

Anti‐Tumor Strategies Targeting Nutritional Deprivation: Challenges and Opportunities
Jinsheng Shi, Wei Han, Jie Wang, et al.
Advanced Materials (2025)
Closed Access

NSUN6-mediated 5-methylcytosine modification of NDRG1 mRNA promotes radioresistance in cervical cancer
Min Yu, Mengdong Ni, Fei Xu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 5

Tumor battlefield within inflamed, excluded or desert immune phenotypes: the mechanisms and strategies
Siwei Zheng, Wenwen Wang, Lesang Shen, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 5

Writers, readers, and erasers RNA modifications and drug resistance in cancer
Di Chen, Xinyu Gu, Yeltai Nurzat, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 5

NSUN4 mediated RNA 5-methylcytosine promotes the malignant progression of glioma through improving the CDC42 mRNA stabilization
Zhen Zhao, Yujie Zhou, Peng Lv, et al.
Cancer Letters (2024) Vol. 597, pp. 217059-217059
Open Access | Times Cited: 4

Aggregation-Induced Emission Luminogen: Role in Biopsy for Precision Medicine
Yanhong Duo, Lei Han, Yaoqiang Yang, et al.
Chemical Reviews (2024) Vol. 124, Iss. 20, pp. 11242-11347
Open Access | Times Cited: 4

IGF2 promotes alveolar bone regeneration in murine periodontitis via inhibiting cGAS/STING-mediated M1 macrophage polarization
Tairan Wang, Yi Tang, Yuxing Xia, et al.
International Immunopharmacology (2024) Vol. 132, pp. 111984-111984
Closed Access | Times Cited: 3

Metabolic regulation of innate immunity in cancer immunotherapy
Yuheng Liao, Hui Yang
Cancer Biology and Medicine (2024) Vol. 20, Iss. 12, pp. 898-902
Open Access | Times Cited: 3

Epitranscriptomic cytidine methylation of the hepatitis B viral RNA is essential for viral reverse transcription and particle production
Pei-Yi Su, C Y Chang, Shin-Chwen Bruce Yen, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 24
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top